ketanserin has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mastropasqua, L | 1 |
| Costagliola, C | 2 |
| Ciancaglini, M | 1 |
| Carpineto, P | 1 |
| Gallenga, PE | 1 |
| Fasano, ML | 1 |
| Iuliano, G | 1 |
| Ferrara, LA | 1 |
2 trials available for ketanserin and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, | 1997 |
Effects of ketanserin on intraocular pressure.
Topics: Adult; Blood Pressure; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Ket | 1990 |